Mylan Specialty, LP clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 2 studies whose lead sponsor is Mylan Specialty, LP. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 7, 2023.

Before and after it joined Viatris Inc.

First submitted before Mylan Specialty, LP became part of Viatris Inc.: 1
First submitted after Mylan Specialty, LP became part of Viatris Inc.: 1
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Terminated: 1
Completed: 1

Phase

Phase 2: 2

Where

United States: 2

Registry sponsor names on this page

Mylan Specialty, LP2 studies

Something wrong with this grouping? Tell us on the Viatris Inc. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Viatris Inc. studies →

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.CompletedNCT05317312Phase 2
Sponsor listed in the registry: Mylan Specialty, LP · First submitted after Mylan Specialty, LP became part of Viatris Inc.
Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom PoisoningTerminatedNCT00915681Phase 2
Sponsor listed in the registry: Mylan Specialty, LP · First submitted before Mylan Specialty, LP became part of Viatris Inc.